Biok passes the GMP site review by State Ministry of Agriculture

On June 19-21, a team of four experts appointed by the State Ministry of Agriculture carry out GMP site review. Team members inspect veterinary medicine production workshop, check documents on veterinary drug production. After three days of audit, audit team agrees that the company's production is in line with the GMP standards of veterinary drugs, and also, the quality management has been upgraded with continuous technological innovations.

As early as in 2001, Biok has introduced GMP standard in veterinary drug production and quality management system. In that same year, its Avermectin was certified by US FDA as starting material for veterinary drugs. In 2003, Biok was GMP certified by the Ministry of Agriculture, for liquid injection production line (later for the development, the liquid injection line has been fully combined into the subsidiary, Zhejiang Eco-Biok Animal Health Products Co., Ltd.). Three years after, all Biok veterinary drugs have got GMP certification, including, Colistin Sulfate, Flavomycoin, Monensin, Diclazuril, Tilmicosin, Ivermectin, and Nicarbazin, Tiamulin raw materials, feed-grade Salinomycin powder and premix. At the same time, Biok also receive annual audits by domestic and foreign customers. Alone in 2008, there are five key customers from the United States, Europe and other countries and regions, make audits to Biok.

Each review or audit means a big leap forward on quality management. Since the introduction of GMP system, Biok continues to improve and optimize the facilities, strengthen the overall controlling system, upgrade product quality, to provide customers with excellent products in accordance with the requirements of GMP norms.